Immunogenic cell death in cancer therapy - PubMed (original) (raw)
Review
Immunogenic cell death in cancer therapy
Guido Kroemer et al. Annu Rev Immunol. 2013.
Abstract
Depending on the initiating stimulus, cancer cell death can be immunogenic or nonimmunogenic. Immunogenic cell death (ICD) involves changes in the composition of the cell surface as well as the release of soluble mediators, occurring in a defined temporal sequence. Such signals operate on a series of receptors expressed by dendritic cells to stimulate the presentation of tumor antigens to T cells. We postulate that ICD constitutes a prominent pathway for the activation of the immune system against cancer, which in turn determines the long-term success of anticancer therapies. Hence, suboptimal regimens (failing to induce ICD), selective alterations in cancer cells (preventing the emission of immunogenic signals during ICD), or defects in immune effectors (abolishing the perception of ICD by the immune system) can all contribute to therapeutic failure. We surmise that ICD and its subversion by pathogens also play major roles in antiviral immune responses.
Similar articles
- Immunogenic cancer cell death: a key-lock paradigm.
Tesniere A, Apetoh L, Ghiringhelli F, Joza N, Panaretakis T, Kepp O, Schlemmer F, Zitvogel L, Kroemer G. Tesniere A, et al. Curr Opin Immunol. 2008 Oct;20(5):504-11. doi: 10.1016/j.coi.2008.05.007. Epub 2008 Jun 23. Curr Opin Immunol. 2008. PMID: 18573340 Review. - Molecular characteristics of immunogenic cancer cell death.
Tesniere A, Panaretakis T, Kepp O, Apetoh L, Ghiringhelli F, Zitvogel L, Kroemer G. Tesniere A, et al. Cell Death Differ. 2008 Jan;15(1):3-12. doi: 10.1038/sj.cdd.4402269. Epub 2007 Nov 16. Cell Death Differ. 2008. PMID: 18007663 Review. - Inducers of immunogenic cancer cell death.
Dudek AM, Garg AD, Krysko DV, De Ruysscher D, Agostinis P. Dudek AM, et al. Cytokine Growth Factor Rev. 2013 Aug;24(4):319-33. doi: 10.1016/j.cytogfr.2013.01.005. Epub 2013 Feb 5. Cytokine Growth Factor Rev. 2013. PMID: 23391812 Review. - Human tumor cells killed by anthracyclines induce a tumor-specific immune response.
Fucikova J, Kralikova P, Fialova A, Brtnicky T, Rob L, Bartunkova J, Spísek R. Fucikova J, et al. Cancer Res. 2011 Jul 15;71(14):4821-33. doi: 10.1158/0008-5472.CAN-11-0950. Epub 2011 May 20. Cancer Res. 2011. PMID: 21602432 - Immunogenic cell death modalities and their impact on cancer treatment.
Kepp O, Tesniere A, Schlemmer F, Michaud M, Senovilla L, Zitvogel L, Kroemer G. Kepp O, et al. Apoptosis. 2009 Apr;14(4):364-75. doi: 10.1007/s10495-008-0303-9. Apoptosis. 2009. PMID: 19145485 Review.
Cited by
- Perylene-Mediated Electron Leakage in Respiratory Chain to Trigger Endogenous ROS Burst for Hypoxic Cancer Chemo-Immunotherapy.
Zhang B, Zheng R, Liu Y, Lou X, Zhang W, Cui Z, Huang Y, Wang T. Zhang B, et al. Adv Sci (Weinh). 2023 Jan;10(3):e2204498. doi: 10.1002/advs.202204498. Epub 2022 Nov 14. Adv Sci (Weinh). 2023. PMID: 36373677 Free PMC article. - Ivermectin converts cold tumors hot and synergizes with immune checkpoint blockade for treatment of breast cancer.
Draganov D, Han Z, Rana A, Bennett N, Irvine DJ, Lee PP. Draganov D, et al. NPJ Breast Cancer. 2021 Mar 2;7(1):22. doi: 10.1038/s41523-021-00229-5. NPJ Breast Cancer. 2021. PMID: 33654071 Free PMC article. - The role of myeloid cells in cancer therapies.
Engblom C, Pfirschke C, Pittet MJ. Engblom C, et al. Nat Rev Cancer. 2016 Jul;16(7):447-62. doi: 10.1038/nrc.2016.54. Nat Rev Cancer. 2016. PMID: 27339708 Review. - Prognostic and immunological implications of heterogeneous cell death patterns in prostate cancer.
Wang M, Dai B, Liu Q, Zhang X. Wang M, et al. Cancer Cell Int. 2024 Aug 24;24(1):297. doi: 10.1186/s12935-024-03462-7. Cancer Cell Int. 2024. PMID: 39182081 Free PMC article. - Local anesthetics and immunotherapy: a novel combination to fight cancer.
Bezu L, Kepp O, Kroemer G. Bezu L, et al. Semin Immunopathol. 2023 Mar;45(2):265-272. doi: 10.1007/s00281-022-00960-6. Epub 2022 Aug 31. Semin Immunopathol. 2023. PMID: 36044068 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources